Medical Educational Resource
LGMD2I/R9 – Disease State Overview, Biomarkers, and BBP-418 Clinical Update Registration
Activity Snapshot
Join Carla Zingiarello, DO (University of Florida) and Douglas Sproule, MD (CMO, ML BioSolutions) as they give an overview of LGMD2I/R9, discuss potential biomarkers of disease, and give an update on the BBP-418 clinical program.